StockDriftsStockDriftsTop 49 Ghost Tree Capital, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 8.95% | 300.0K | $29.6M | +20.00%(+50.00K) | — | 2024-09-30 | |
| SRPT | SAREPTA THERAPEUTICS INC | 4.53% | 120.0K | $15.0M | +118.18%(+65.00K) | — | 2024-09-30 | |
| NVO | NOVO-NORDISK A S | 3.96% | 110.0K | $13.1M | new | — | 2024-09-30 | |
| BPMC | BLUEPRINT MEDICINES CORP | 3.91% | 140.0K | $12.9M | +250.00%(+100.00K) | — | 2024-09-30 | |
| AXSM | AXSOME THERAPEUTICS INC | 3.66% | 135.0K | $12.1M | -10.00%(-15.00K) | — | 2024-09-30 | |
| TARS | TARSUS PHARMACEUTICALS INC | 3.48% | 350.0K | $11.5M | +48.94%(+115.00K) | — | 2024-09-30 | |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3.02% | 750.0K | $10.0M | -18.92%(-175.00K) | — | 2024-09-30 | |
| CGON | CG ONCOLOGY INC | 2.85% | 250.0K | $9.4M | -3.85%(-10.00K) | — | 2024-09-30 | |
| ROIV | ROIVANT SCIENCES LTD | 2.79% | 800.0K | $9.2M | -20.00%(-200.00K) | — | 2024-09-30 | |
| PCVX | VAXCYTE INC | 2.76% | 80.0K | $9.1M | -46.67%(-70.00K) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Ghost Tree Capital, Llc reports $331.04M in US-listed equity holdings across 54 positions in its most recent 13F filing. Its largest disclosed positions are XBI (8.9%), SRPT (4.5%) and NVO (4.0%). Figures reflect the Q3 2024 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Ghost Tree Capital, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ghost Tree Capital, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1595851). View Ghost Tree Capital, Llc’s 13F filings on SEC